Universe Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Universe Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 20% to $32,308,735. The net income raised on -$6,163,061 and profit margin reached -19%. Total operating expenses were $13,841,908.
Profit Margin
| 2018 | 28.51M | 7.60M | 26.66% |
|---|---|---|---|
| 2019 | 33.22M | 7.55M | 22.73% |
| 2020 | 30.70M | 7.55M | 24.62% |
| 2021 | 47.98M | 11.31M | 23.59% |
| 2022 | 40.14M | -8.73M | -21.76% |
| 2023 | 32.30M | -6.16M | -19.08% |
UPC Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 32.30M | 40.14M | 47.98M | 30.70M | 33.22M | 28.51M |
Cost of revenue | 21.99M | 18.25M | 22.65M | 16.61M | 19.82M | 15.10M |
Gross profit | 10.31M | 21.89M | 25.32M | 14.09M | 13.40M | 13.40M |
Operating exp. | ||||||
Research and development | 4.85M | 7.64M | 5.46M | 583.12K | 618.43K | 789.38K |
Selling and marketing | 6.78M | 19.08M | 2.97M | 1.55M | 1.57M | 1.68M |
Total operating expenses | 13.84M | 28.91M | 11.73M | 3.74M | 3.35M | 3.64M |
Operating income | -3.52M | -7.01M | 13.59M | 10.25M | 9.75M | 9.65M |
Other income (expenses), net | -322.8K | -964.70K | 88.33K | -151.29K | -99.76K | -76.80K |
Income before tax | -3.84M | -7.98M | 13.67M | 10.10M | 9.65M | 9.51M |
Income tax expense | 2.31M | 752.41K | 2.35M | 2.54M | 2.10M | 1.91M |
Net income | -6.16M | -8.73M | 11.31M | 7.55M | 7.55M | 7.60M |
Earnings per share | ||||||
Basic EPS | -1.7 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
Diluted EPS | -1.7 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| Data source | Data source | Data source |